Tech Company Financing Transactions
Theradaptive Funding Round
Theradaptive closed a $26 million Series A funding round on 6/15/2023. Backers included private investors.
Transaction Overview
Company Name
Announced On
6/15/2023
Transaction Type
Venture Equity
Amount
$26,000,000
Round
Series A
Investors
Proceeds Purpose
The funds will enable the company to continue its work to meet regulatory requirements and scale up Good Manufacturing Practices in preparation for first-in-human clinical trials later this year. Investment will also support the expansion of the Theradaptive platform beyond orthopedics to additional indications such as oncology and dental. The round brings Theradaptive's total funding to over $50 million. The company has previously been awarded non-dilutive grant funding from the Department of Defense, as well as the Maryland Stem Cell Research Fund.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5350 Partners Court B
Frederick, MD 21703
USA
Frederick, MD 21703
USA
Phone
Website
Email Address
Overview
Theradaptive is developing a therapeutic delivery platform for multiple clinical indications including immuno-oncology, orthopedics and soft tissue repair.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Luis Alvarez
Vice President
David Stewart
Browse more venture capital transactions:
Prev: 6/15/2023: Blackbird.AI venture capital transaction
Next: 6/15/2023: Northstar Clean Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs